Procter & Gamble (Large Cap) Share Target 2024, 2025 To 2039
|
Procter & Gamble Hygiene and Health Care Limited |
|||
|
Price: ₹15,114.75 | ||
| 52 Week Low: ₹15,001.00 52 Week High: ₹17,745.00 |
|||
| Market Capital: 51,354.94 Crore (Largecap) | |||
| Consumer Defensive -> Household & Personal Products | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Procter & Gamble Share Price Target For 2024
- 1.1.1: Procter & Gamble Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Procter & Gamble Share Price Target For 2025
- 1.2.1: Procter & Gamble Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Procter & Gamble Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Procter & Gamble Brief Company Overview
- 4: Procter & Gamble Financial Performance
- 4.0.1: Is Procter & Gamble A Good Buy For Long Term?
To predict the Procter & Gamble's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Procter & Gamble Share Price Target For 2024
The line chart displays the monthly closing prices of Procter & Gamble with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Procter & Gamble shares in 2024, see the table below.
Procter & Gamble Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 15610.05 (+3.27%) | Price Action: 16 Dec 2024 Low |
| 2024 Target 2 | 15448.79 (+2.21%) | Price Action: 28 Oct 2024 Low |
| 2024 Target 1 | 15282.85 (+1.11%) | Price Action: 19 Dec 2024 Low |
| Current Price | 15114.75 | Procter & Gamble's share price as of 20 Dec 2024 |
| Stop Loss 1 | 15033.55 (-0.54%) | Price Action: Chart |
| Stop Loss 2 | 14754.16 (-2.39%) | Fibonacci Retracement Level 28.20% |
| Stop Loss 3 | 14535.16 (-3.84%) | Price Action: Sep 2022 High |
Short-Term Technical Outlook
Current Technical Position: Procter & Gamble is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹15769.61 serves as the nearest technical reference point.
Historical Returns: 3-month: -8.80% | 6-month: -8.46% | 1-year: -11.90%
Procter & Gamble Share Price Target For 2025
The line chart displays the monthly closing prices of Procter & Gamble with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Procter & Gamble shares in 2025, see the table below.
Procter & Gamble Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 17220.19 (+13.92%) | Fibonacci Extension Level 82.00% |
| 2025 Target 2 | 16961.68 (+12.21%) | Price Action: Jun 2024 High |
| 2025 Target 1 | 16781.13 (+11.02%) | Fibonacci Extension Level 64.90% |
| Current Price | 15114.75 | Procter & Gamble's share price as of 20 Dec 2024 |
| Stop Loss 1 | 14535.16 (-3.84%) | Price Action: Sep 2022 High |
| Stop Loss 2 | 14345.93 (-5.09%) | Fibonacci Retracement Level 28.20% |
| Stop Loss 3 | 14192.83 (-6.10%) | Price Action: Jan 2023 High |
Long-Term Technical Outlook
52-Week Range Analysis: Procter & Gamble is currently trading near its 52-week low of ₹15001, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -11.90% | 3-year: +1.24% | 5-year: +41.31%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Procter & Gamble Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹15,114.75 | ||
| 2024 | ₹16,542.00 | +9.44% | ₹16,790.13 |
| 2025 | ₹16,043.37 | -3.01% | ₹16,381.08 |
| 2026 | ₹15,503.50 | -3.37% | ₹16,310.93 |
| 2027 | ₹15,088.40 | -2.68% | ₹16,077.73 |
| 2028 | ₹15,232.30 | +0.95% | ₹15,844.54 |
| 2029 | ₹15,608.45 | +2.47% | ₹15,842.58 |
| 2030 | ₹15,127.62 | -3.08% | ₹15,455.74 |
| 2031 | ₹14,608.35 | -3.43% | ₹15,378.14 |
| 2032 | ₹14,207.04 | -2.75% | ₹15,144.94 |
| 2033 | ₹14,332.01 | +0.88% | ₹14,911.74 |
| 2034 | ₹14,674.90 | +2.39% | ₹14,895.02 |
| 2035 | ₹14,211.87 | -3.16% | ₹14,530.40 |
| 2036 | ₹13,713.20 | -3.51% | ₹14,445.35 |
| 2037 | ₹13,325.68 | -2.83% | ₹14,212.15 |
| 2038 | ₹13,431.73 | +0.80% | ₹13,978.95 |
| 2039 | ₹13,745.75 | +2.34% | ₹13,951.94 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Procter & Gamble Brief Company Overview
Procter & Gamble Hygiene and Health Care Limited: A Healthcare and FMCG Giant Procter & Gamble Hygiene and Health Care Limited, a subsidiary of The Procter & Gamble Company, is a leading manufacturer and distributor of branded consumer goods in India and globally. Since its...
inception in 1964, the company has built a strong reputation in the industry, offering a diverse product range that caters to various household and personal care needs. Key Products and Services: Health Care: Ointments, creams, cough drops, tablets Hygiene: Feminine hygiene products, skin care hygiene products, feminine care pads Baby Care: Nappies, pants, baby wipes Laundry: Ariel, Tide Hair Care: Gillette, Head & Shoulders, Herbal Essences, Pantene Home Care: Ambi Pur Oral Care: Oral-B Beauty: Olay, Old Spice Market Presence: Procter & Gamble Hygiene and Health Care Limited has a strong market presence, distributing its products through various channels, including mass merchandisers, grocery stores, and online platforms.Procter & Gamble Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 51,354.94 Crore | Market valuation of Procter & Gamble's shares. |
| Revenue (TTM) | 4,126.47 Crore | Total revenue generated by Procter & Gamble over the past twelve months. |
| Net Income (TTM) | +7,452,000,256.00 | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +24.22% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +18.05% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+13.50% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-6.50% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
0.34 | Company's total debt divided by total shareholder equity. |
| Total Debt | 3.58 Crore | Sum of Procter & Gamble's current & long-term financial obligations. |
| Total Cash | 702.42 Crore | Total amount of liquid funds available to Procter & Gamble. |
| Beta | 0.18 | Beta is less than 1 indicating that the Procter & Gamble's price is less volatile than the market. |
Is Procter & Gamble A Good Buy For Long Term?
Procter & Gamble's long-term investment potential appears favorable. Despite a recent dip in earnings and a moderate debt level, the company has a strong revenue growth rate, a healthy profit margin, and a substantial market capitalization. Its consistent performance over the past three to five years further strengthens its appeal as a potential long-term investment.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
